Associated Papers
Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing.
Wessman S et al.
Cancers, 2021
[Ovarian cancer is in many ways a heterogeneous disease].
Malander S et al.
Lakartidningen, 2015
First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm.
Arver B et al.
Genetic Testing, 2001
Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.
Wagner T et al.
Genomics, 1999
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.
Johannsson O et al.
European Journal of Cancer (oxford, England : 1990), 1999
Select a paper to view details